Cantor Fitzgerald’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Cantor Fitzgerald’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,035,000	Closed	-$1.03M	–	755
2023 Q1	$1.03M	Buy	+1,035,000	New	+$10.6M	0.02%	368
2022 Q3	–	Sell	-400,000	Closed	-$4.01M	–	901
2022 Q2	$4.01M	Hold	400,000	–	–	0.08%	274
2022 Q1	$4M	Buy	+400,000	New	+$3.97M	0.3%	89

Cantor Fitzgerald's IQMD Position: Q2 2023 in Review

Cantor Fitzgerald sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 1,035,000 shares — an estimated $1.03M sold.

Cantor Fitzgerald first reported a position in IQMD in Q1 2022 and held it in 3 quarters. The position peaked at $4.01M in Q2 2022. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Cantor Fitzgerald reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Cantor Fitzgerald sold 1,035,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.03M.
Cantor Fitzgerald first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
Cantor Fitzgerald's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.01M in Q2 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.